RxDoctor Payments Data

Peter Larned

Foot Surgery · King Of Prussia, PANPI 1093142614

Payments from drug & device makers

What this record shows

17 manufacturers reported payments, led by Liberty Surgical Inc. at 54.6% of the total. Reporting peaked in 2021 at $1,305 and has fallen 90.6% since, to $122 in 2025. Among foot surgery clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,139in general payments, 2019–2025

Across 46 payments — averaging $68.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Liberty Surgical Inc.$2K
  • Stryker$492
  • Smith+Nephew$360
  • Eclipse Technology Solutions Inc.$151
  • Medtronic$112
  • Treace Medical Concepts, Inc.$66
  • plus $245 from 11 others

What the payments were for

  • Food & beverage$1,53349%
  • Education$1,60651%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,139 in reported general payments places this provider in the 90th percentile of 67 foot surgery providers in Pennsylvania.

See all foot surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$113,386
Medicare patients
362
Services billed
1,548

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole26$631
Cephalexin42$259
Gabapentin25$228
Mupirocin22$171
Oxycodone Hcl13$43

Paid to pharmacies, not to this prescriber.

Other foot surgery in King Of Prussia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →